Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?

European Journal of Cancer

Volumn 39, Issue 7, 2003, Pages 932-944

  Vrieling, C ^a   Collette, L ^b   Fourquet, A ^c   Hoogenraad, W J ^d   Horiot, J C ^e   Jager, J J ^f   Oei, S Bing ^g   Peterse, H L ^a   Pierart, M ^b   Poortmans, P M ^g   Struikmans, H ^h   Van Den Bogaert, W ⁱ   Bartelink, H ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b EORTC DATA CENTER   (Belgium)

^c INSTITUT CURIE   (France)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CENTRE GEORGES FRANÇOIS LECLERC   (France)

^f RTIL   (Netherlands)

^g DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Breast cancer; Breast conserving therapy; Local recurrence; Young age

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER THERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TUMOR VOLUME;

EID: 0346037295     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00123-0     Document Type: Article

References (50)

1. Sarrazin D., Lê M.G., Arriagada R.et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother. Oncol. 14:1989;177-184.
2. Blichert-Toft M., Rose C., Andersen J.A.et al. Danish randomized trial comparing breast conservation therapy with mastectomy. six years of life-table analysis Monogr. Natl. Cancer Inst. 11:1992;19-25.
3. Veronesi U., Salvadori B., Luini A.et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur. J. Cancer. 31A:1995;1574-1579.
4. Fisher B., Anderson S., Redmond C.K., Wolmark N., Wickerham D.L., Cronin W.M. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 333:1995;1456-1461.
5. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N. Engl. J. Med. 333:1995;1444-1455.
6. Van Dongen J.A., Voogd A.C., Fentiman I.S.et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy. European Organization for Research and Treatment of Cancer 10801 trial J. Nat. Cancer Inst. 92:2000;1143-1150.
7. Voogd A.C., Nielsen M., Peterse J.L.et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer. pooled results of two large European randomized trials J. Clin. Oncol. 19:2001;1688-1697.
8. Bonnier P., Romain S., Charpin C.et al. Age as a prognostic factor in breast cancer. relationship to pathologic and biologic features Int. J. Cancer. 62:1995;138-144.
9. De la Rochefordière A., Asselain B., Campana F.et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet. 341:1993;1039-1043.
10. Kollias J., Elston C.W., Ellis I.O., Robertson J.F.R., Blamey R.W. Early-onset breast cancer - histopathological and prognostic considerations. Br. J. Cancer. 75:1997;1318-1323.
11. Albain K.S., Allred D.C., Clark G.M. Breast cancer outcome and predictors of outcome. are there age differentials? Monogr. Natl. Cancer Inst. 16:1994;35-42.
12. Nixon A.J., Neuberg D., Hayes D.F.et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J. Clin. Oncol. 12:1994;888-894.
13. Winchester D.P., Osteen R.T., Menck H.R. The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer. 78:1996;1838-1843.
14. Marcus J.N., Watson P., Page D.L., Lynch H.T. Pathology and heredity of breast cancer in younger women. Monogr. Natl. Cancer Inst. 16:1994;23-34.
15. Crowe J.P., Gordon N.H., Shenk R.R., Zollinger R.M., Brumberg D.J., Shuck J.M. Age does not predict breast cancer outcome. Arch. Surg. 129:1994;483-488.
16. Halverson K.J., Perez C.A., Taylor M.E.et al. Age as a prognostic factor for breast and regional nodal recurrence following breast conserving surgery and irradiation in stage I an II breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;1045-1050.
17. Remvikos Y., Magdelenat H., Dutrillaux B. Genetic evolution of breast cancers III. age-dependent variations in the correlations between biological indicators of prognosis Breast Cancer Res. Treat. 34:1995;25-33.
18. Fowble B.L., Schultz D.J., Overmoyer B.et al. The influence of young age on outcome in early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;23-33.
19. Tsuchiya A., Abe R., Kanno M.et al. Role of age as a prognostic factor in breast cancer. Surg. Today. 27:1997;213-216.
20. Recht A., Connolly J.L., Schnitt S.J.et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;3-10.
21. Bartelink H., Horiot J.C., Poortmans P.et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 345:2001;1378-1387.
22. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer. experience from a large study with long-term follow-up Histopathol. 19:1991;403-410.
23. Gaffney II E.V., Venz-Williamson T.L., Hutchinson G., Biggs P.J., Nelson K.M. Relationship of standardized mitotic indices to other prognostic factors in breast cancer. Arch. Pathol. Lab. Med. 120:1996;473-477.
24. Baak J.P., Van Dop H., Kurver P.H., Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer. 56:1985;374-382.
25. Holland R., Peterse J.L., Millis R.R.et al. Ductal carcinoma in situ. a proposal for a new classification Semin. Diagn. Pathol. 11:1994;167-180.
26. Lehmann E.L. Nonparametrics: Statistical Methods Based on Ranks. 1975;Holden-Day, San Francisco, CA.
27. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22:1959;719-748.
28. Armitage P. Test for linear trend in proportions and frequencies. Biometrics. 11:1955;375-386.
29. Miller R.G. Jr. Simultaneous Statistical Inference. 1981;Springer Verlag, New York.
30. Cox D.R., Snell E.J. Analysis of Binary Data. 2nd ed. 1989;Chapmann and Hall, London.
31. Cox D.R., Oakes D. Analysis of Survival Data. 4th ed. 1990;Chapmann and Hall, London.
32. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Statis. Ass. 53:1958;457-481.
33. Vicini F., Recht A., Abner A., Silver B., Harris J.R. The association between very young age and recurrence in the breast in patients treated with conservative surgery and radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 19(Suppl. 1):1990;132.
34. Regine W.F., Kramer C.A. To boost or not to boost? It's not the only question! Int. J. Radiat. Oncol. Biol. Phys. 32:1995;273.
35. Scholl P., Byers R.M., Batsakis J.G., Wolf P., Santini H. Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications. Am. J. Surg. 152:1986;354-360.
36. Wazer D.E., Schmidt-Ullrich R.K., Schmid C.H.et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;291-299.
37. Solin L.J., Fowble B., Martz K., Pajak T.F., Goodman R.L. Results of re-excisional biopsy of the primary tumor in preparation for definitive irradiation of patients with early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;721-725.
38. Kemperman H. Breast Conserving Therapy. Experience at The Netherlands Cancer Institute with Special Interest for the Problem of Local Recurrence. 1998;ICG Printing, Dordrecht, NL.
39. Stadler B., Staffen A., Strasser K., Wrba F., Stanek C. Prognostic factors for local recurrence in patients with limited surgery and irradiation of breast cancer. Strahlenther. Onkol. 166:1990;453-456.
40. Schnitt S.J., Connolly J.L., Harris J.R., Hellman S., Cohen R.B. Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer. 53:1984;1049-1057.
41. Borger J., Kemperman H., Hart A., Peterse H., van Dongen J., Bartelink H. Risk factors in breast-conservation therapy. J. Clin. Oncol. 12:1994;653-660.
42. Heimann R., Powers C., Halpern H.J.et al. Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience. Cancer. 78:1996;1722-1730.
43. Nixon A.J., Schnitt S.J., Gelman R.et al. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer. 78:1996;1426-1431.
44. Ptaszynski A., Van den Bogaert W., Van Glabbeke M.et al. Patient population analysis in the EORTC trial 22881/10882 on the role of a booster dose in breast-conserving therapy. Eur. J. Cancer. 30A:1994;2073-2081.
45. Bartelink H., Borger J.H., van Dongen J.A., Peterse J.L. The impact of tumor size and histology on local control after breast-conserving therapy. Radiother. Oncol. 11:1988;297-303.
46. Sinn H.P., Anton H.W., Magener A., von Fournier D., Bastert G., Otto H.F. Extensive and predominant in situ component in breast carcinoma. their influence on treatment results after breast-conserving therapy Eur. J. Cancer. 34:1998;646-653.
47. Holland R., Connolly J.L., Gelman R.et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J. Clin. Oncol. 8:1990;113-118.
48. Wazer D.E., Schmidt-Ullrich R.K., Ruthazer R.et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int. J. Radiat. Oncol. Biol. Phys. 45:1999;885-891.
49. Vicini F.A., Eberlein T.J., Connolly J.L.et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann. Surg. 214:1991;200-204.
50. Van't Veer L.J., Dai H., van de Vijver M.J.et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536.